The purpose of this study is to investigate the micro ribonucleic acid (mRNA) profiles of patients with EIA without allergic sensitization and EIA with house dust mite sensitization compared to that of healthy controls.
Who can participate
Age range12 Years – 24 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
For EIA patients
Inclusion Criteria:
* written agreement
* age \>=12 and \<= 24
* known exercise induced asthma
* Group 1: skin prick test positiv house-dust allergy, eNO \> 30 ppb, MCT PD20 \< 0,1 mg
* Group 2: skin prick test negative house-dust allergy, eNO \< 20 ppb, MCT PD20 \< 1 mg
* lung function before ECC forced vital capacity (FVC) ≥ 75% and forced exspiratory pressure in one second (FEV1) ≥ 70%
Exclusion Criteria:
* age \< 12 und \> 24 years
* lung function FVC \< 75% und FEV1\< 70%
* inability to understand the range of the study
* chronic asthma with systemic cortisone therapy
* regular therapy with inhalative corticosteroids or leukotriene-antagonists \<14 days before visit 1
* intake of long acting beta-agonists (LABA) 48 h before examination
* intake of short acting beta-agonists (SABA) 8 h before examination
* acute severe infection (pneumonia) within the last 4 weeks
* other chronic diseases or infections (HIV, Tbc)
* pregnancy
For healthy controls
Inclusion Criteria:
* written agreement
* age \>=18 and \<= 24
Exclusion Criteria:
* age \< 18 and \> 24 years
* known asthma bronchiale or other chronic lung diseases
* lung function FVC \< 90% and FEV1 \< 80%
* allergic sensitization in skin prick test
* eNO \> 30 ppb
* inability to understand the range of the study
* acute severe infection (pneumonia) within the last 4 weeks
* other chronic diseases or infections (HIV, Tbc)
* pregnancy